Cynosure Lutronic Achieves CE Mark Approval for Mosaic 3D™
In a significant development, Cynosure Lutronic, a pioneering force in energy-based medical aesthetic technologies, has proudly announced that Mosaic 3D™ has been granted CE Mark approval under the stringent European MDR. This achievement highlights the company's dedication to expanding global access to their innovative fractional resurfacing platform.
Promise of Mosaic 3D™ in Aesthetic Treatments
Mosaic 3D™ is designed to deliver enhanced energy levels while treating larger skin areas, ensuring patient comfort with minimal downtime. Its introduction in selected international markets reflects the growing trust among healthcare professionals and patients alike.
Advanced Features That Make a Difference
One of the standout features is the 3D Controlled Chaos Technology™, which optimizes microbeam distribution and depth. This technology minimizes the risk of thermal damage, allowing practitioners to achieve greater coagulation volume during treatments safely.
Cooling Mechanism for Optimal Comfort
Additionally, the device includes an integrated cooling system, specifically designed to address sensitive areas such as the eyes and mouth. The combination of air cooling and unique sapphire tips works in harmony to enhance treatment efficacy while prioritizing patient comfort.
Versatility in Treatment Applications
Mosaic 3D™ enhances neocollagenesis and neoelastinogenesis, revitalizing and brightening the skin. With upgraded metal rollers and sapphire tips, the platform offers both rolling and stamping capabilities, allowing for tailored treatments that yield exceptional results.
Clinical Recognition from Experts Worldwide
The device is currently utilized in clinical practices and studies by respected experts worldwide, including Dr. Guy Erlich from Israel, Professor Merete Haedersdal from Denmark, and Dr. Tatiana Kuznechenkova from the UAE. Their experiences affirm the impressive adaptability and control offered by Mosaic 3D™, making it a favored choice for varied resurfacing needs.
According to Dr. Erlich, "Mosaic 3D™ presents a new level of control in fractional resurfacing, demonstrating excellent tissue response during clinical and research applications. It truly represents a shift in treatment capabilities." Meanwhile, Professor Haedersdal highlighted the positive outcome of their clinical studies, which are set to be showcased at upcoming medical conferences.
Highlighting Innovations at IMCAS 2026
Building upon its recent CE approval, Mosaic 3D™ is set to be spotlighted at the IMCAS World Congress 2026. Cynosure Lutronic will lead a scientific symposium featuring Dr. Erlich and Professor Haedersdal, focused on the advantages and clinical data surrounding Mosaic 3D™. This platform aims to foster exchanges of knowledge among leading professionals in the field.
About Cynosure Lutronic
With over three decades of combined expertise, Cynosure Lutronic excels in developing non-invasive and minimally invasive aesthetic treatments. The company caters to dermatologists, plastic surgeons, and aesthetic practitioners globally, offering a wide range of solutions in skin resurfacing, hair removal, and body contouring. Their operational reach extends through direct sales and partnerships across numerous countries.
The commitment of Cynosure Lutronic to innovation remains unwavering, continuously striving to enhance patient outcomes through advanced technologies. Their passion for excellence is the driving force behind their efforts to empower healthcare professionals worldwide.
Frequently Asked Questions
What is Mosaic 3D™?
Mosaic 3D™ is an advanced fractional laser technology designed for non-ablative skin treatments, focusing on minimal downtime and enhanced comfort for patients.
What are the benefits of 3D Controlled Chaos Technology™?
This technology optimizes the depth and distribution of microbeams, thereby minimizing thermal damage and enhancing treatment efficiency.
Who are some of the key opinion leaders using Mosaic 3D™?
Notable experts include Dr. Guy Erlich, Professor Merete Haedersdal, and Dr. Tatiana Kuznechenkova, who utilize Mosaic 3D™ in their clinical practices.
What major event will showcase Mosaic 3D™?
Mosaic 3D™ will be featured at the IMCAS World Congress 2026, where Cynosure Lutronic will conduct a dedicated symposium.
What commitment does Cynosure Lutronic have towards innovation?
Cynosure Lutronic is dedicated to advancing technologies that empower healthcare providers and improve patient outcomes worldwide, reflecting their commitment to evidence-based innovation.
